BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22595227)

  • 21. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
    Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
    Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.
    Dickinson SC; Vankemmelbeke MN; Buttle DJ; Rosenberg K; Heinegård D; Hollander AP
    Matrix Biol; 2003 May; 22(3):267-78. PubMed ID: 12853037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein.
    Guo F; Lai Y; Tian Q; Lin EA; Kong L; Liu C
    Arthritis Rheum; 2010 Jul; 62(7):2023-36. PubMed ID: 20506400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of cartilage oligomeric matrix protein in dogs with naturally developing and experimentally induced arthropathy.
    Misumi K; Vilim V; Carter SD; Ichihashi K; Oka T; Sakamoto H
    Am J Vet Res; 2002 Apr; 63(4):598-603. PubMed ID: 11939326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments.
    Morozzi G; Fabbroni M; Bellisai F; Pucci G; Galeazzi M
    Ann N Y Acad Sci; 2007 Jun; 1108():398-407. PubMed ID: 17894003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population.
    Taylor SE; Weaver MP; Pitsillides AA; Wheeler BT; Wheeler-Jones CP; Shaw DJ; Smith RK
    Equine Vet J; 2006 Nov; 38(6):502-7. PubMed ID: 17124839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids.
    Hummel KM; Neidhart M; Vilim V; Hauser N; Aicher WK; Gay RE; Gay S; Häuselmann HJ
    Br J Rheumatol; 1998 Jul; 37(7):721-8. PubMed ID: 9714346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury.
    Kühne SA; Neidhart M; Everson MP; Häntzschel H; Fine PR; Gay S; Häuselmann HJ; Gay RE
    Rheumatol Int; 1998; 18(1):21-5. PubMed ID: 9672995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.
    Geng H; Carlsen S; Nandakumar KS; Holmdahl R; Aspberg A; Oldberg A; Mattsson R
    Arthritis Res Ther; 2008; 10(6):R134. PubMed ID: 19014566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
    Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
    Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood.
    Saxne T; Heinegård D
    Br J Rheumatol; 1992 Sep; 31(9):583-91. PubMed ID: 1381980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
    Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
    PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.
    Skiöldebrand E; Ekman S; Mattsson Hultén L; Svala E; Björkman K; Lindahl A; Lundqvist A; Önnerfjord P; Sihlbom C; Rüetschi U
    Equine Vet J; 2017 Sep; 49(5):662-667. PubMed ID: 28097685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
    Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
    Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
    Wisłowska M; Jabłońska B
    Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    El Defrawy AO; Gheita TA; Raslan HM; El Ansary MM; El Awar AH
    Z Rheumatol; 2016 Nov; 75(9):917-923. PubMed ID: 26683321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids.
    Misumi K; Vilim V; Clegg PD; Thompson CC; Carter SD
    Osteoarthritis Cartilage; 2001 Feb; 9(2):119-27. PubMed ID: 11237659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China.
    Tang X; Zhou Z; Shen B; Yang J; Kang P; Li J; Crook N; Li Q; Min L; Pei F
    Rheumatol Int; 2012 Nov; 32(11):3503-9. PubMed ID: 22068351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.